Nu Skin Enterprises (NYSE:NUS) Issues FY 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 0.900-1.300 for the period, compared to the consensus EPS estimate of 0.760. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.7 billion. Nu Skin Enterprises also updated its Q1 2025 guidance to 0.100-0.200 EPS.

Nu Skin Enterprises Stock Performance

Shares of NUS stock opened at $7.54 on Friday. Nu Skin Enterprises has a 52 week low of $5.95 and a 52 week high of $14.64. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53. The company’s fifty day simple moving average is $6.89 and its two-hundred day simple moving average is $7.49.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 5.81% and a positive return on equity of 5.47%. As a group, research analysts predict that Nu Skin Enterprises will post 0.68 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th will be paid a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 3.19%. The ex-dividend date is Monday, February 24th. Nu Skin Enterprises’s payout ratio is currently -11.59%.

Wall Street Analysts Forecast Growth

NUS has been the topic of several recent research reports. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th. Citigroup decreased their target price on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd. Finally, DA Davidson decreased their target price on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.